Australia markets closed

Botanix Pharmaceuticals Limited (BOT.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.2750-0.0050 (-1.79%)
At close: 04:10PM AEST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
30/06/2023
30/06/2022
30/06/2021
30/06/2020
Total revenue
92.867
102.934
-
-
-
Gross profit
437.215
102.934
-
-
-
Operating expenses
Research development
1,615
5,727
10,293
6,571
13,699
Selling general and administrative
4,183
3,038
3,556
2,244
8,252
Total operating expenses
10,478
12,899
15,941
10,267
24,259
Operating income or loss
-10,041
-12,796
-15,941
-10,267
-24,259
Interest expense
11.691
81.736
37.44
55.941
50.982
Total other income/expenses net
-60.346
3,658
2,770
6,885
7,399
Income before tax
-10,024
-9,154
-13,171
-3,334
-16,731
Income tax expense
0
0
0
0
0
Income from continuing operations
-10,024
-9,154
-13,171
-3,334
-16,731
Net income
-10,024
-9,154
-13,171
-3,334
-16,731
Net income available to common shareholders
-10,024
-9,154
-13,171
-3,334
-16,731
Basic EPS
-0.01
-0.01
-0.01
-0.00
-0.02
Diluted EPS
-0.01
-0.01
-0.01
-0.00
-0.02
Basic average shares
1,153,952
1,153,952
973,142
972,935
936,371
Diluted average shares
1,153,952
1,153,952
973,142
972,935
936,371